| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1097/MOH.0B013E328302C9C5 |
| P698 | PubMed publication ID | 18536582 |
| P2093 | author name string | Mitchell R Smith | |
| P433 | issue | 4 | |
| P921 | main subject | mantle cell lymphoma | Q268713 |
| P304 | page(s) | 415-421 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Current Opinion in Hematology | Q15757961 |
| P1476 | title | Mantle cell lymphoma: advances in biology and therapy | |
| P478 | volume | 15 |
| Q36060239 | Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans |
| Q28730808 | Blockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphoma |
| Q37398843 | Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells |
| Q35144981 | Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells |
| Q38343572 | Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis |
| Q36637130 | Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathology |
| Q39190247 | Gene methylation and silencing of SOCS3 in mantle cell lymphoma |
| Q42761995 | Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta(12,14)-prostaglandin J(2) requires Nrf2. |
| Q42580235 | Interleukin 22 signaling promotes cell growth in mantle cell lymphoma |
| Q38353509 | Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism |
| Q39291545 | NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy. |
| Q38132359 | Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance |
| Q33614363 | Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples |
| Q37424558 | Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis |
| Q46146766 | Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cyta |
| Q34091061 | Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line |
| Q34168461 | Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells. |
| Q54159065 | Secondary central nervous system involvement in cyclin D1-negative mantle cell lymphoma. |
| Q42323712 | The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice? |
| Q28478591 | Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies |
| Q56882990 | Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma |
| Q35146262 | Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma |
| Q36606941 | Two cases of systemic mantle cell lymphoma involving the skin |
Search more.